Search Results 1001-1010 of 18601 for hepatitis

1. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

   Positive test for antibodies to hepatitis ... Known positive serology for hepatitis C (unless due to immunoglobulin therapy or completely resolved natural ...

2. A Safety, Methodological and Exploratory Biomarkers Study to Slow Disease Progression - Mayo Clinic

   History of +VE test result indicating active hepatitis C or B (defined as both hepatitis B surface antigen and hepatitis core antibody +VE). Uncontrolled ...

3. Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML - Mayo Clinic

   ... hepatitis B surface antigen (HBsAg), negative anti- hepatitis B core protein (HBc) and positive antibody to the HBsAg (anti-HBs) are not excluded; Subjects ...

4. Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris - Mayo Clinic

   Have hepatitis C virus (HCV) infection (hepatitis C antibody-positive and HCV ribonucleic acid [RNA]-positive). Note: Patients who have documented anti-HCV ...

5. A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) (SKYSCRAPER-14) - Mayo Clinic

   Co-infection with hepatitis B virus (HBV) and hepatitis C virus (HCV). Acute Epstein-Barr virus (EBV) infection or known or suspected chronic active EBV ...

6. Overview - Data Analytics and AI for Advanced Liver Disease - Mayo Clinic Research

   His research interests include investigating treatments for alcohol-associated hepatitis, cirrhosis and vascular diseases of the liver. He is committed to ...

7. Elivaldogene autotemcel (intravenous route) - Mayo Clinic

   Hepatitis A Vaccine, Inactivated; Hepatitis B Vaccine; Human Papillomavirus Vaccine; Influenza Virus Vaccine; Influenza Virus Vaccine, Live; Japanese ...

8. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   Have active hepatitis B or hepatitis C defined as: HBV: hepatitis B surface ... hepatitis B core antibody (HBc Ab) positive subjects;; HCV: HCV ...

9. Publications - Membrane Trafficking in Disease - Mayo Clinic Research

   The large GTPase dynamin is required for hepatitis B virus protein secretion from hepatocytes. Journal of Hepatology. 2003; doi:10.1016/s0168-8278(02)00326 ...

10. A Study to Evaluate the Safety and Effectiveness of TT-00420 in Adults with Advanced Cholangiocarcinoma - Mayo Clinic

    Evidence of active infection with Hepatitis B or Hepatitis C that is not adequately controlled. For patients with known prior history of Hepatitis B or ...